Sarah graduated from Imperial College School of Medicine with first-class Honours in Physiology (BSc), and distinctions in Pathology and Surgery. She undertook general medical training at Northwick Park Hospital and University College Hospital before switching to a career in General Practice in 2005. She is an accredited member of both the Royal College of Physicians and the Royal College of General Practitioners. In 2016 she completed a Master of Science (MSc) degree in allergy and immunology at Imperial College, passing her exams with distinction.

 

Sarah is active in research, and has published extensively on clinical outcomes in women treated with hormone replacement therapy (HRT) including testosterone, and the role of HRT after breast cancer diagnosis. She co-authored two chapters for a book,  Principles of Precision Hormone Therapy for Healthy Aging, published in 2025. She contributed to the updated British Society of Sexual Medicine Position Statement for Management of Genitourinary Syndrome of the Menopause (GSM), and was a clinical advisor for the recently published NICE technology appraisal concerning the use of fezolinetant for the treatment of menopausal vasomotor symptoms (ID5071). She is currently working with Professor Jayant Vaidya, Professor of Breast Surgery and Oncology, setting up a clinical trial to study breast cancer and non-breast cancer outcomes in women who choose to take HRT after breast cancer (the Menopausal hormone therapy Outcomes After Breast Cancer trial, or MENO-ABC trial). For more information about the study, please register your interest here: https://www.londonbreastcancer.com/meno-abc-trial.

 

Sarah is passionate about teaching and education and has created several patient resources to support shared decision making and patient-centred care. She is a member of the British Menopause Society, the Menopause Society (aka the North American Menopause Society), and the International Menopause Society. Outside work, Sarah is focussed on her family, travelling, art, and keeping healthy. 

​

Prices:

​​

• New patient breast cancer consultation (1 hour): £300

• New patient Long COVID consultation (1 hour): £300

• New patient menopause consultation (45 mins): £275

• Follow-up consultations (30 mins): £225

​

Clinic times:

​​

• Wednesdays - Remote consultations via Zoom 

• Thursdays - Face to face consultations as well as Zoom

​

Dr Glynne is not covered by insurance so all patients will be seen as self-pay.  Payment is required at the time of booking to secure the appointment.

​